| Alzheimer’s
Disease
Two Alzheimer vaccines developed by Affiris, AFFITOPE
AD01 and AFFITOPE AD02, have successfully passed the
preclinical development phase and are entering the stage
of clinical testing.
Information on AFFITOPE AD01/AFFiRiS
001
Information on AFFITOPE AD02/AFFiRiS
002
Atherosclerosis
In preparation
|